5-Quinone derivatives of 2'-deoxyuridine 5'-phosphate: inhibition and inactivation of thymidylate synthase, antitumor cell, and antiviral studies — Laman A. Al‐Razzak (1987) | RDL Network
5-Quinone derivatives of 2'-deoxyuridine 5'-phosphate: inhibition and inactivation of thymidylate synthase, antitumor cell, and antiviral studies
Article 1987 en
Authors
LA
Laman A. Al‐Razzak
DS
Douglas Schwepler
CD
Charles J. Decedue
Abstract
1 min read
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXT5-Quinone derivatives of 2'-deoxyuridine 5'-phosphate: inhibition and inactivation of thymidylate synthase, antitumor cell, and antiviral studiesLaman A. Al-Razzak, Douglas Schwepler, Charles J. Decedue, Jan Balzarini, Erik De Clercq, and Mathias P. MertesCite this: J. Med. Chem. 1987, 30, 2, 409–419Publication Date (Print):February 1, 1987Publication History Published online1 May 2002Published inissue 1 February 1987https://pubs.acs.org/doi/10.1021/jm00385a026https://doi.org/10.1021/jm00385a026research-articleACS PublicationsRequest reuse permissionsArticle Views346Altmetric-Citations20LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
Discussion(0)
No comments yet. Be the first to comment.